Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

09 Oct 2018

21.04

0.96%

Company Update

Statement Of Investor Complaints For The Quarter Ended September 2018

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- SANDIP KUMAR LALDesignation :- Company Secretary and Compliance Officer

Bharat Immunological & Biologicals Corporation Ltd.

28 Sep 2018

21.04

0.96%

AGM

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

30 Aug 2018

21.04

0.96%

Corp. Action

Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (21.09.2018 To …

BSE India

In compliance with the provision of LODR, 2015, it is intimated that, for the financial year 2017-18, the 29th Annual General Meeting of the Company is Scheduled to be held on 28th September 2018 (Friday) at 11.00 a.m. at registered office of the Company, OPV Plant , Village Chola, Bulandshahr, Uttar Pradesh - 203203, and the Register of Members and Share Transfer Books of the Company will remain closed from 21/09/2018 to 28/09/2018 both days inclusive.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

29 Aug 2018

21.04

0.96%

AGM

Submission Of Notice Of 29Th Annual General Meeting On 28.09.2018 As Compliance Of The Provision Of …

BSE India

In pursuance of the provision of LODR 2015 please find attached herewith the Notice of 29th Annual General Meeting of the Company on 28 09 2018 for the financial year 2017 18 The draft 29th Annual Report in respect of financial year ending on 31 03 2018 will be placed at Annual General Meeting for approval by shareholders on 28 09 2018 Attached The Notice calling 29th Annual General Meeting on 28 09 2018 is submitted for kind information and record please

pdf

Bharat Immunological & Biologicals Corporation Ltd.

23 Jul 2018

21.04

0.96%

Result

Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended June …

BSE India

In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 30th June 2018. It is requested to kindly take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

20 Jul 2018

21.04

0.96%

Result

Submission Of Unaudited Quarterly Financial Results For The Quarter Ended June 2018 As Compliance Of LODR …

BSE India

In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended June 2017 approved by the Board of the Company in its Meeting on 19.07.2018. This submission of UAFR will succeeded by XBRL filing as per the requirement of Exchange. Submitted please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

16 Jul 2018

21.04

0.96%

Company Update

Shareholding for the Period Ended June 30, 2018

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

04 Jul 2018

21.04

0.96%

Board Meeting

Board Meeting - Board Meeting On 19/07/2018

BSE India

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 19th July 2018, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 30th June 2018.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

31 May 2018

21.04

0.96%

Result

Results Of FY 2017-18

BSE India

Submitted of Audited Balance Sheet and Statement of P/L for the year 2017-18

pdf

Bharat Immunological & Biologicals Corporation Ltd.

16 May 2018

21.04

0.96%

Company Update

Certificate From Practicising Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For The Half …

BSE India

Sir/Madam, In pursuance of Regulation 40 of the LODR with Stock Exchange, please find attached the Certificate from Practicising Company Secretary for the half year ended 31st March 2018. It is requested to take the above on record please. Thanking you

pdf

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

136 Votes:

Buy 69.85%

Sell 14.71%

Hold 15.44%